1. Home
  2. APLS vs PDCO Comparison

APLS vs PDCO Comparison

Compare APLS & PDCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • PDCO
  • Stock Information
  • Founded
  • APLS 2009
  • PDCO 1877
  • Country
  • APLS United States
  • PDCO United States
  • Employees
  • APLS N/A
  • PDCO N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • PDCO Medical Specialities
  • Sector
  • APLS Health Care
  • PDCO Health Care
  • Exchange
  • APLS Nasdaq
  • PDCO Nasdaq
  • Market Cap
  • APLS 3.3B
  • PDCO 2.7B
  • IPO Year
  • APLS 2017
  • PDCO 1992
  • Fundamental
  • Price
  • APLS $24.27
  • PDCO $31.21
  • Analyst Decision
  • APLS Buy
  • PDCO Hold
  • Analyst Count
  • APLS 18
  • PDCO 9
  • Target Price
  • APLS $45.53
  • PDCO $26.74
  • AVG Volume (30 Days)
  • APLS 1.7M
  • PDCO 1.1M
  • Earning Date
  • APLS 05-06-2025
  • PDCO 02-26-2025
  • Dividend Yield
  • APLS N/A
  • PDCO 2.50%
  • EPS Growth
  • APLS N/A
  • PDCO N/A
  • EPS
  • APLS N/A
  • PDCO 1.55
  • Revenue
  • APLS $781,367,000.00
  • PDCO $6,511,188,000.00
  • Revenue This Year
  • APLS $12.95
  • PDCO $2.46
  • Revenue Next Year
  • APLS $21.35
  • PDCO $2.91
  • P/E Ratio
  • APLS N/A
  • PDCO $20.20
  • Revenue Growth
  • APLS 97.02
  • PDCO N/A
  • 52 Week Low
  • APLS $23.25
  • PDCO $19.45
  • 52 Week High
  • APLS $59.91
  • PDCO $31.79
  • Technical
  • Relative Strength Index (RSI)
  • APLS 40.15
  • PDCO 66.01
  • Support Level
  • APLS $23.25
  • PDCO $31.16
  • Resistance Level
  • APLS $24.88
  • PDCO $31.18
  • Average True Range (ATR)
  • APLS 0.91
  • PDCO 0.04
  • MACD
  • APLS 0.11
  • PDCO -0.01
  • Stochastic Oscillator
  • APLS 38.35
  • PDCO 52.94

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About PDCO Patterson Companies Inc.

Patterson Companies Inc is a dental distributor and wholesaler of consumable products and equipment operating through two business segments, Patterson Dental, and Patterson Animal Health. The company's segment includes Dental, Animal Health, and Corporate. It generates maximum revenue from the Animal Health segment. Geographically, it derives its revenue from the United States, the United Kingdom, and Canada. The firm derives almost all of its revenue from the United States.

Share on Social Networks: